However, their analysis shows that patients had the greatest risk of NAION in the first year after they were prescribed semaglutide, which suggests the condition could be drug-induced
In the withdrawal trial, participants switched to placebo regained about 14% over the following year. Tapering, protein at roughly 0.7 g per pound, resistance training, and follow-up reduce the risk, but no post-stop protocol guarantees maintenance
For contexts where rapid and reliable serum levels are essential, injection remains preferred
The trials include at-risk groups, including women at different life stages and patients with multiple metabolic conditions
Fact: Compounding is a legal, regulated pharmacy practice that provides essential access to medications during shortages or when customization is required